Cytarabine Injection

DRUG3 trials

Sponsors

Won Seog Kim, La Raza Medical Center, Hospital Municipal São José

Conditions

Acute Myeloid LeukemiaPrimary CNS LymphomaRefractory Non-Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma

Phase 1

Outpatient Administration of R-DHAP in Relapsed/Refractory Non-Hodgkin Lymphoma

CompletedNCT03892421

La Raza Medical CenterRefractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma

Start: 2018-04-05End: 2021-04-30Updated: 2021-05-18

Phase 2

[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma

Won Seog KimPrimary CNS Lymphoma

Start: 2018-11-30End: 2025-06-30Target: 35Updated: 2020-10-22

Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia

RecruitingNCT06537843

Hospital Municipal São JoséAcute Myeloid Leukemia

Start: 2023-12-01End: 2028-07-01Target: 100Updated: 2024-08-05

Related Papers

Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma

Hematological Oncology2023-06-01